A Unique Case of SCN2A Variant-Associated Catatonia and Response to Electroconvulsive Therapy
- 14 May 2024
- journal article
- case report
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 40 (3) , 199-200
Abstract
The SCN2A gene encodes a subunit that forms part of voltage-gated sodium channels in the brain. Gain-of-function mutations are associated with epilepsy as well as numerous movement/motor abnormalities. Loss-of-function mutations may also cause epilepsy in addition to a variety of neurodevelopmental anomalies, including autism and intellectual disability. The occurrence of catatonia has also been described in 1 previous report that involved a 4-year-old boy. We describe a 20-year-old intellectually disabled female patient who developed recurrent catatonic symptoms in her teenage years that remitted with electroconvulsive therapy. This is only the second report of catatonia occurring in relation to an SCN2A mutation and the first involving a female. Moreover, this case is unique given our patient's later age of symptom onset and given that her symptoms responded well to electroconvulsive therapy.Keywords
This publication has 7 references indexed in Scilit:
- When to consider electroconvulsive therapy (ECT)Acta Psychiatrica Scandinavica, 2019
- Scn2a Haploinsufficiency in Mice Suppresses Hippocampal Neuronal Excitability, Excitatory Synaptic Drive, and Long-Term Potentiation, and Spatial Learning and MemoryFrontiers in Molecular Neuroscience, 2019
- Scn2a haploinsufficient mice display a spectrum of phenotypes affecting anxiety, sociability, memory flexibility and ampakine CX516 rescues their hyperactivityMolecular Autism, 2019
- Treatment of catatonia in autism spectrum disordersActa Psychiatrica Scandinavica, 2018
- Catatonia Associated With a SCN2A-Related Disorder in a 4-Year-Old ChildPediatrics, 2018
- Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in miceCommunications Biology, 2018
- CatatoniaCNS Spectrums, 2016